Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Amyotrophic Lateral Sclerosis (ALS) / Dementia Panel Centogene AG - the Rare Disease Company Germany | 64 | 66 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Nuclear Mitochondrial Disorders Panel Invitae United States | 394 | 319 |
|
Congenital Anomalies of the Gastrointestinal Tract Panel PreventionGenetics, part of Exact Sciences United States | 297 | 180 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Invitae United States | 638 | 419 |
|
Hereditary Spastic Paraplegia Comprehensive Panel PreventionGenetics, part of Exact Sciences United States | 87 | 106 |
|
Pure Hereditary Spastic Paraplegia Panel PreventionGenetics, part of Exact Sciences United States | 31 | 36 |
|
Mitochondrial Disorders Panel (Nuclear Genes Only) PreventionGenetics, part of Exact Sciences United States | 292 | 253 |
|
Spastic Paraplegia 13 via the HSPD1 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Invitae Hereditary Spastic Paraplegia Comprehensive Panel Invitae United States | 98 | 62 |
|
Baylor Genetics United States | 842 | 637 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Hypomyelinating Leukodystrophy NGS Panel Fulgent Genetics United States | 225 | 62 |
|
SPASTIC PARAPLEGIA, FAMILIAL (AUTOSOMAL DOMINANT) Laboratorio de Genetica Clinica SL Spain | 11 | 11 |
|
HSP, Complete Dominant Evaluation Athena Diagnostics United States | 17 | 10 |
|
Athena Diagnostics United States | 40 | 24 |
|
Fulgent Genetics United States | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.